期刊文献+

不同剂量辛伐他汀的调脂疗效比较 被引量:2

Comparison of therapeutic effect of different dosages of simvastatin on patients with hyperlipoidemia
下载PDF
导出
摘要 目的:观察不同剂量的辛伐他汀对高脂血症病人的疗效与安全性。方法:80例病人随机分为A、B两组,A组辛伐他汀剂量为20mg/d,B组为5mg/d,门诊治疗6周。试验前后分别测定血脂、肝功能及磷酸肌酸激酶。结果:A组的达标率为70%,而B组的达标率仅为23%。两组均未发现明显的肝功能损害及肌病。其余不良反应发生率基本相似。结论:20mg/d的辛伐他汀调整血脂作用比5mg/d的更好,而且使用安全。 Objective: To evaluate lipid-lowering effect of a large dose(20 mg/d) of simvastatin and compare it with that of small dose (5 mg/d) of simvastatin. Methods: Eighty patients were randomized to two groups. Simvastatin dosage was 20 mg/d for group A and 5 mg/d for group B. The follow-up period was 6 weeks. Blood lipids were determined before and after the study. Liver function and creatine phosphate kinase concentration were also determined. Results: Group A had a more marked lipid-lowering effect than group B. The target-reaching rate in group A was 70%, which was much higher than that in group B(23%). There was no severe liver dysfunction or myopathy in both groups. The incidence of other drug adverse effect was quite low, and there was no significant difference between the 2 groups. Conclusion: Simvastatin 20 mg/d is more effective than 5 mg/d simvastatin, and can be used safely in clinical practice.
出处 《药学服务与研究》 CAS CSCD 2002年第2期102-103,共2页 Pharmaceutical Care and Research
关键词 辛伐他汀 降血脂药 药物剂量效应关系 安全性 高脂血症 simvastatin antilipemic agents dose-response relationship, drug
  • 相关文献

参考文献4

  • 1Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholes-terolemia. West of Scotland Coronary Prevention Study Group[J]. N Engl J Med, 1995, 333(20):1301.
  • 2Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) [J]. Lancet, 1994, 344(8934):1383.
  • 3方圻,王钟林,宁田海,邵耕,陈在嘉,陆宗良,李健斋,林传骧,周北凡,诸骏仁,诸永康,陶萍,陶寿淇,龚兰生,顾复生,游凯,戴玉华.血脂异常防治建议[J].中华心血管病杂志,1997,25(3):169-175. 被引量:3067
  • 4Pitt B, Mancini GB, Ellis SG, et al. Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC I): reduction in atherosclerosis progression and clinical events. PLAC I investigation [J]. J Am Coll Cardiol, 1995, 26(5):1133.

共引文献3066

同被引文献9

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部